🇺🇸 FDA

Intelligence · Patent portfolio

Compass Therapeutics Patents

Full USPTO pharma patent portfolio for Compass Therapeutics — grant dates, expiration, and drug cross-links.

Patents
100
Expiring ≤24m
0

Quick answer

Compass Therapeutics has 100 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 3

  1. US 10806740

    Natural combination hormone replacement formulations and therapies

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10806697

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10716851

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10675288

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10668082

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10639375

    Progesterone formulations

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10568891

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10537581

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10532059

    Steroid hormone pharmaceutical composition

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10519175

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10471072

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10471148

    Progesterone formulations having a desirable PK profile

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10434175

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10398708

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10369098

    Methods for localized drug delivery

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10350292

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10328087

    Formulations for solubilizing hormones

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10286077

    Steroid hormone compositions in medium chain oils

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10279038

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10279040

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10279039

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10258630

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10231974

    Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10206932

    Natural combination hormone replacement formulations and therapies

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10098894

    Transdermal cream

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10052386

    Progesterone formulations

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9974853

    Immunoregulatory peptides and methods of use

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9931349

    Steroid hormone pharmaceutical composition

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9855305

    Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9301920

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9289382

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9248136

    Transdermal hormone replacement therapies

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9187530

    Immunoregulatory peptides and methods of use

    Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9180091

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9150616

    Immunoregulatory peptides and methods of use

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9150617

    Immunoregulatory peptides and methods of use

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9114145

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9114146

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9012434

    Natural combination hormone replacement formulations and therapies

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9006222

    Natural combination hormone replacement formulations and therapies

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8993548

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8993549

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8987238

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8987237

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8933059

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8846648

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8846649

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8633178

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Compass Therapeutics have?

100 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Compass Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.